I told you to get some exposure to copper back when the red metal was trading below $2.50. I knew there was absolutely no way copper could stay at those levels very long...
Nowhere else in our history have we seen a comeback story like the U.S. oil industry. By 2007, most people had written off our domestic oil production...
To those of you who’ve been reading Energy and Capital for the last couple months have heard this time and time again, and once again, I’m going to say it: Lithium’s real growth cycle is only...
They’re smart to go for Russia’s energy infrastructure, but the consequences are already being felt globally. Overnight, the price of Brent crude jumped and was hovering around $87 per barrel...
Joe Rogan, Ray Kurzweil Reveal the Truth about Renewable Energy
Last summer, during a geological survey of the caldera’s remnants, this giant funnel of long-cooled Earth’s innards spewed upwards from the depths was found to contain enormous deposits of...
If you’re unfamiliar, EN-23 is a valuable class of molecules that drastically improves brain function. It’s actually one of the biggest breakthroughs medical science has seen in 50 years...
Today, we live in a world of MORE. More people, more technology, more demand… more, more, more. It’s a never-ending cycle of growth over the long run, and no matter how much the media headlines...
Over the last year or so, the going rate for lithium has collapsed from almost $80,000 per ton to today’s prices ranging in the low $20,000s...
For your weekly reading, we bring you the week's most popular stories from Energy and Capital and our sister site, Wealth Daily.
Over the last few weeks, we’ve been talking about the delusional narrative that the mainstream media has had over the past year, particularly when it came to the supply and demand fundamentals for...
While EN-23 isn’t necessarily new, the FDA is expected to approve the nation’s first EN-23 medication in August developed by company called Lykos Therapeutics.